US Archives - Page 6 of 129 - European Medical Journal

A Step Forward Against Chronic Kidney Disease Itch

Dupilumab may provide meaningful relief for patients with chronic kidney disease who experience uremic pruritus and for those with atopic dermatitis complicated by renal impairment, according to a retrospective real-world study.

Survival Clues from Necrotising Lung Infections in Critical Care

Necrotising lung infections (NLI) significantly affect the course and outcomes of patients requiring veno-venous extracorporeal membrane oxygenation (VV-ECMO).

Exploring the Effect of Parkinson’s Therapies on Vision

Visual symptoms in Parkinson’s disease may remain largely unchanged despite treatment with levodopa or deep brain stimulation.

Folinic Acid Combination May Help Extend Options in Pancreatic Cancer

Patients with unresectable pancreatic cancer who receive second-line treatment with nanoliposomal irinotecan in combination with fluorouracil and folinic acid may remain eligible for subsequent third-line chemotherapy.

Hidden Threats: Donor-Derived Infections in Heart and Lung Transplants

Donor-derived infections are a significant concern for heart and lung transplant recipients, with established and emerging pathogens creating complex challenges for post-transplant care, according to new research.

Accreditation Drives Better Safety and Care in Hospitals

Accreditation in tertiary care hospitals is associated with significant improvements in patient safety, operational efficiency, and staff satisfaction.

The Future of Predicting Kidney Survival in Vasculitis

Predicting long-term kidney outcomes in patients with ANCA-associated vasculitis (AAV) may be improved by integrating additional clinical markers into existing risk models, according to new research.

Long-Term Study Supports Steroid-Free Kidney Transplants

Steroid avoidance combined with low-dose tacrolimus has been shown to be both safe and effective for kidney transplant recipients over the long term, according to new follow-up data from the SAILOR trial.

Six Months to Better Outcomes in Vitiligo?

Oral JAK inhibitors appear effective and safe in the treatment of vitiligo, according to a retrospective study evaluating real-world outcomes in nearly 100 patients.

How a Global Consensus Is Redefining COVID-19 Treatment for Organ Recipients

Solid organ transplant (SOT) recipients face a heightened risk of severe outcomes from SARS-CoV-2 infection, yet clinical evidence specific to this vulnerable group remains limited.